Opsigtsvækkende resultater indenfor behandling af myelomatose

BestPractice | Juni 5, 2018 |

PÅ ASCO 2018 blev der fremlagt flere interessante nye data i forhold til behandling af myelomatose. I denne MEDtalk bliver du præsenteret for udvalgte nyheder , eksempelvis Car T Cell-terapi – en ny potent behandling.

#

Seneste nyheder

Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Click and hear Paul G. Richardson present the data for...
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Despite recent advances in MM therapy, the disease remains incurable....